iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares SENORES SENORES PHARMACEUTICALS LIMITED INE0RB801010 Board Meeting New 2025-11-06 Yes 2025-10-01 2025-11-10 Financial results Other business Unaudited Standalone And Consolidated Quarterly September 2025 Please refer to our earlier intimation dated September 26, 2025, whereby, pursuant to the Company’s Code of Conduct framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended (“the Code”), the Trading Window for dealing in securities of the Company, for persons specified under the Code, was closed from October 01, 2025 till 48 hours after the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2025 are approved by the Board of Directors and submitted to Stock Exchanges.